Skip to main content
SpringerLink
Log in

New Concepts in Atrial Defibrillation

  • Published:
Journal of Interventional Cardiac Electrophysiology Aims and scope Submit manuscript

Abstract

External cardioversion of AF is an established and accepted method for termination of individual episodes of AF. Recent advances have taken place in the area of non-pharmacologic management of AF, and despite its long history and well established technique, defibrillation has not been spared from these advances. The success of low-energy internal atrial defibrillation for the termination of both chronic and acute onset atrial fibrillation has resulted in the development of implantable defibrillators that treat this arrhythmia. Many of the advances have come about as a result of the use of defibrillation in implanted devices for recurrent AF due to the substantial efforts in an attempt to make this form of restoration of sinus rhythm more efficacious and tolerable to the patient.

Additionally, the use of other non-pharmacologic control of atrial fibrillation has also been recently explored, namely the use of ablation and atrial pacing. The use of these other non-pharmacologic therapies are likely to both reduce the recurrence rate, as well as enhance the efficacy of defibrillation. However, defibrillation is likely to still be needed to terminate atrial fibrillation for persistent episodes, and its combination with these other therapies is likely synergistic.

Electrical therapy to restore sinus rhythm for persistent episodes of atrial fibrillation is likely to be perceived by the patient. Therefore, the concept of patient controlled therapy from implanted devices to treat atrial fibrillation has shown promising results and will likely be a requirement of such devices in the future.

Major advances in defibrillation therapy for atrial fibrillation have been made and have resulted in the development of implantable atrial defibrillators. Despite these advances in defibrillation and other therapies for atrial fibrillation, it is likely that combined pharmacologic and non-pharmacologic therapies for atrial fibrillation will prevail over the individual entities themselves. Future study is needed to determine the best therapy or combination of therapies for individual patients with atrial fibrillation

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Lown B, Amarasingham R, Neuman J. New method for terminating cardiac arrhythmias: Use of synchronized capacitor discharge. JAMA 1962;182:548–555.

    Google Scholar 

  2. Murgatroyd FD, Slade AKB, Sopher SM, Rowland E, Ward DE, Camm AJ. Efficacy and tolerability of transvenous low energy cardioversion of paroxysmal atrial fibrillation in humans. J Am Coll Cardiol 1995;25:1347–1353.

    Google Scholar 

  3. Schmitt C, Alt E, Plewan A, Ammer R, Leibig M, Karch M, Schömig A. Low energy intracardiac cardioversion after failed conventional external cardioversion of atrial fibrillation. J Am Coll Cardiol 1996;28:994–999.

    Google Scholar 

  4. Lévy S, Ricard P, Lau CP, Lok NS, Camm AJ, Murgatroyd FO, Jordaens L, Kappenberger LJ, Brugada P, Ripley KL. Multicenter low energy transvenous atrial defibrillation (XAD) trial results in different subsets of atrial fibrillation. J Am Coll Cardiol 1997;29:750–755.

    Google Scholar 

  5. Levy S, Camm J. An implantable atrial defibrillator: an impossible dream? Circulation 1993;87:1761–1769.

    Google Scholar 

  6. Wellens HJJ, Lau CP, Lüderitz B, Akhtar M, Waldo AM, Camm AJ, Timmermans C, Tse HF, Jung W, Jordaens L, Ayers G. for the Metrix Investigators. The atrial defibrillator: An implantable device for the treatment of atrial fibrillation. Circulation 1998;98:1651–1656.

    Google Scholar 

  7. Tse HF, Lau CP, Sra JS, Crijns HJGM, Edvardsson N, Kacet S, Wyse G, for the Metrix Investigators. Atrial fibrillation detection and R-wave synchronization by Metrix implantable atrial defibrillator: Implications for long-term efficacy and safety. Circulation 1999;99:1446–1451.

    Google Scholar 

  8. Fellows CL, Hoyt RH, Sra JS, Ayers GM. Clinical use of the MetrixTM implantable atrial defibrillator. Circulation 1998;96:I-190.

    Google Scholar 

  9. Lerman B, Stein K, Markowitz S. Worldwide experience with the model 7250 Jewel AF dual chamber arrhythmia device. PACE 1998;21:872

    Google Scholar 

  10. Ammer R, Alt E, Ayers G, et al. Pain threshold for low energy intracardiac cardioversion of atrial fibrillation with low or no sedation. Pacing Clin Electrophysiol 1997;20:230–236.

    Google Scholar 

  11. Harbinson MT, Allen JD, Imam Z, et al. Rounded biphasic waveform reduces energy requirements for transvenous catheter cardioversion of atrial fibrillation and flutter. Pacing Clin Electrophysiol 1997;20:226–229.

    Google Scholar 

  12. Gonzalez X, Wagner D, Muff D, et al. Reduced atrial defibrillation thresholds by increasing coil length in a single pass lead. Pacing Clin Electrophysiol 1997;20:1149.

    Google Scholar 

  13. Timmermans C, Rodriguez LM, Ayers GM, Lambert H, Vanegas D, Smeets JRLM, Wellens HJJ. Effect of catheter electrode length on atrial defibrillation thresholds. J Am Coll Cardiol 1998;31:37A.

    Google Scholar 

  14. Geiger MJ, Mongeon L, Kearney MM, et al. Effects of an additional electrode on atrial defibrillation in patients. Pacing Clin Electrophysiol 1996;19:6624.

    Google Scholar 

  15. Cooper RAS, Plumb VJ, Epstein AE, et al. Marked reduction in internal atrial defibrillation thresholds with dual current pathways and sequential shocks in humans. Circulation 1998 (In Press).

  16. Lok NS, Lau CP, Leung WH. Effect of sotalol on transvenous atrial defibrillation for acute and chronic atrial fibrillation. J Am Coll Cardiol 1995;25:109A.

    Google Scholar 

  17. Boriani G, Biffi M, Bronzetti G, Ayers GM, Zannoli R, Branzi A, Capucci A, Magnani B. Efficacy and tolerability in fully conscious patients of transvenous low-energy internal atrial cardioversion for atrial fibrillation. Am J of Cardiol 1998;81(2):241–243.

    Google Scholar 

  18. Timmermans C, Rodriguez LM, Smeets JLRM, Wellens HJJ. Immediate reinitiation of atrial fibrillation following internal atrial defibrillation. J Cardiovasc Electrophysiol 1998;9:122–128.

    Google Scholar 

  19. Lau CP, Tse HF, Ayers GM. Defibrillation-guided radiofrequency ablation of atrial fibrillation secondary to an atrial focus. J Am Coll Cardiol 1999;33:1217–1226.

    Google Scholar 

  20. Haissaguerre M, Jais P, Shah DC, Takahashi A, Hocini M, Quiniou G, Garrigue S, Le Mouroux A, Le Metayer P, Clementy J. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med 1998;339:659–666.

    Google Scholar 

  21. Haïssaguerre M, Jaïs P, Shah DC, Lavergne T, Hocini M, Takahashi A, Barold SS, Clémenty J. Mechanisms of spontaneous initiation of human atrial fibrillation. Pacing Clin Electrophysiol 1998;21:802.

    Google Scholar 

  22. Kalman JM, Olgin JE, Karch MR, Steiner PR, Stillson C, Chin MC, Lesh MD. Effect of right atrial linear lesions on atrial defibrillation threshold. Pacing Clin Electrophysiol 1996;19:625.

    Google Scholar 

  23. Jais P, Haissaguerre M, Shah DC, Takahashi A, Barold S, Clementy J. Catheter ablation for paroxysmal atrial fibrillation: high success rates with ablation in the left atrium. Circulation 1996;94:I-675.

    Google Scholar 

  24. Jais P, Haissaguerre M, Shah DC, Takahashi A, Barold S, Clementy J. Efficacy and safety of linear ablation for paroxysmal atrial fibrillation in the left atrium. Pacing Clin Electrophysiol 1997;20:1100.

    Google Scholar 

  25. Uno K, Khrestian CM, Matsuo K, Tacker, WA, Ayers GM, Waldo AL. Variability of delivered shock energy for intraarial shock to cardiovert atrial flutter in the canine sterile pericarditis model. Circulation 1997;96:I-74.

    Google Scholar 

  26. Capucci A, Aschieri D, Villani GQ. Epidemiology and therapy of atrial fibrillation. Ann Ital Med Int 1996;11:5S-10S.

    Google Scholar 

  27. Daubert C, Gras D, Leclercq C, et al. Biatrial synchronous pacing: A new therapeutic approach to prevent refractory atrial tachyarrhythmias. J Am Coll Cardiol 1995;25:230A.

    Google Scholar 

  28. Saksena S, Prakash A, Hill M, et al. Prevention of recurrent atrial fibrillation with chronic dual-site right atrial pacing. J Am Coll Cardiol 1996;3:687–694.

    Google Scholar 

  29. Prakash A, Saksena S, Hill M, et al. Outcome of patients with drug refractory atrial fibrillation/flutter and bradyarrhythmias using long-term dual site atrial pacing. Pacing Clin Electrophysiol 1995;18:809.

    Google Scholar 

  30. Haffajee C, Stevens S, Mongeon L, et al. High frequency atrial burst pacing for termination of atrial fibrillation. Pacing Clin Electrophysiol 1995:18:804.

    Google Scholar 

  31. Paladino W, Weiss R, Knight B, et al. Failure of multi-site high frequency burst pacing to terminate laboratory induced acute atrial fibrillation. J Am Coll Cardiol 1997;20:470A.

    Google Scholar 

  32. Darpö B, Ayers GM, Bergfeldt L, Linde C, Johansson K, Rosenquist M. Overdrive pacing does not lower atrial defibrillation thresholds in patients with atrial fibrillation. Pacing Clin Electrophysiol 1998:21:812.

    Google Scholar 

  33. Murgatroyd FD, Johnson EE, Cooper RAS, Lau CP, Eckhart A, Kappenburger LJ, Smith JM, Camm AJ, Wharton JM. Safety of low-energy transvenous atrial defibrillation-World experience. Circulation 1994;90:1–14.

    Google Scholar 

  34. Tse HF, Lau CP, Ayers GM. Atrial overdrive pacing for suppression of spontaneous early re-initiation of atrial fibrillation after transvenous atrial defibrillation. J Am Coll Cardiol 1999;33:147A.

    Google Scholar 

  35. Timmermans C, Rodriguez L-M, Ayers GM, Lambert, H Smeets, JLRM Vlaeyen JWS, Albert A, Wellens HJJ. Effect of butorphanol tartrate on shock-related discomfort during internal atrial defibrillation. Circulation 1999;99:1837–1842.

    Google Scholar 

  36. Lévy S, Rodriguez L-M, Camm AJ, Thibault B, Jordaens L, Rosenqvist M, Seidl K-H, Wellens HJJ, for the Metrix Investigators. Number, duration and frequency of non-treated atrial fibrillation episodes observed during the Metrix automatic implantable atrial defibrillator trial. PACE 1998;21.

  37. Wijfffels MC, Kirchhof CJ, Dorland R, Allessie MA. Atrial fibrillation begets atrial fibrillation: A study in awake chronically instrumented goats. Circulation 1995;92:1954–1968.

    Google Scholar 

  38. Keane D, Zhou L, Houghtaling C, McGovern B, Garan H, Ruskin J. Atrial defibrillation energy requirements and activation wavefronts in the first hours of atrial fibrillation. J Am Coll Cardiol 1999;33:146A.

    Google Scholar 

  39. Lok NS, Lau CP, Tse, HF, Ayers GM. Clinical shock tolerability and effect of different right atrial electrode locations on efficacy of low energy human transvenous atrial defibrillation using an implantable lead system. J Am Coll Cardiol 1997;30:1324–1330.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Corvascular Inc., Palo Alto, CA, USA

    Gregory M. Ayers

Authors
  1. Gregory M. Ayers
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ayers, G.M. New Concepts in Atrial Defibrillation. J Interv Card Electrophysiol 4 (Suppl 1), 155–161 (2000). https://doi.org/10.1023/A:1009863522664

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1009863522664

Search

Navigation